Revefenacin (BioDeep_00000229540)
human metabolite
代谢物信息卡片
化学式: C35H43N5O4 (597.3315)
中文名称: 瑞维那新
谱图信息:
最多检出来源 Mus musculus(not specific) 1.3%
分子结构信息
SMILES: CN(CCN1CCC(CC1)OC(=O)NC1=CC=CC=C1C1=CC=CC=C1)C(=O)C1=CC=C(CN2CCC(CC2)C(N)=O)C=C1
InChI: InChI=1S/C35H43N5O4/c1-38(34(42)29-13-11-26(12-14-29)25-40-19-15-28(16-20-40)33(36)41)23-24-39-21-17-30(18-22-39)44-35(43)37-32-10-6-5-9-31(32)27-7-3-2-4-8-27/h2-14,28,30H,15-25H2,1H3,(H2,36,41)(H,37,43)
描述信息
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BB - Anticholinergics
C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent
Revefenacin (TD-4208; GSK1160724) is a potent mAChR antagonist; has a high affinity on M3 receptor with a Ki of 0.18 nM.
同义名列表
8 个代谢物同义名
1-({4-[(2-{4-[({[1,1-biphenyl]-2-yl}-C-hydroxycarbonimidoyl)oxy]piperidin-1-yl}ethyl)(methyl)carbamoyl]phenyl}methyl)piperidine-4-carboximidate; 1-[2-(1-{4-[(4-carbamoylpiperidin-1-yl)methyl]phenyl}-N-methylformamido)ethyl]piperidin-4-yl N-{[1,1-biphenyl]-2-yl}carbamate; Biphenyl-2-ylcarbamic acid 1-(2-((4-(4-carbamoylpiperidin-1-ylmethyl)benzoyl)methylamino)ethyl)piperidin-4-yl ester; revefenacin; Yupelri; TD-4208; GSK1160724; 1-({4-[(2-{4-[({[1,1'-biphenyl]-2-yl}-C-hydroxycarbonimidoyl)oxy]piperidin-1-yl}ethyl)(methyl)carbamoyl]phenyl}methyl)piperidine-4-carboximidate
数据库引用编号
7 个数据库交叉引用编号
- PubChem: 11753673
- HMDB: HMDB0304897
- DrugBank: DB11855
- ChEMBL: CHEMBL3833319
- chemspider: 9928376
- CAS: 864750-70-9
- medchemexpress: HY-15851
分类词条
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
1 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:
- PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。
亚细胞结构定位 | 关联基因列表 |
---|
文献列表
- Arthur Lo, Marie T Borin, David L Bourdet. Population Pharmacokinetics of Revefenacin in Patients with Chronic Obstructive Pulmonary Disease.
Clinical pharmacokinetics.
2021 03; 60(3):391-401. doi:
10.1007/s40262-020-00938-3
. [PMID: 33124005] - David L Bourdet, Suresh Yeola, Sharath S Hegde, Pierre-Jean Colson, Chris N Barnes, Marie T Borin. Revefenacin Absorption, Metabolism, and Excretion in Healthy Subjects and Pharmacological Activity of Its Major Metabolite.
Drug metabolism and disposition: the biological fate of chemicals.
2020 12; 48(12):1312-1320. doi:
10.1124/dmd.120.000103
. [PMID: 32978223] - Marie T Borin, Chris N Barnes, Borje Darpo, Srikanth Pendyala, Hongqi Xue, David L Bourdet. Revefenacin, a Long-Acting Muscarinic Antagonist, Does Not Prolong QT Interval in Healthy Subjects: Results of a Placebo- and Positive-Controlled Thorough QT Study.
Clinical pharmacology in drug development.
2020 01; 9(1):130-139. doi:
10.1002/cpdd.732
. [PMID: 31468714] - Marie T Borin, Arthur Lo, Chris N Barnes, Srikanth Pendyala, David L Bourdet. Pharmacokinetics and safety of revefenacin in subjects with impaired renal or hepatic function.
International journal of chronic obstructive pulmonary disease.
2019; 14(?):2305-2318. doi:
10.2147/copd.s203709
. [PMID: 31632000]